Skip to content

Effects of Mulligan Mobilization With Movement as Compared to Kaltenborn Joint Mobilization in the Management of Knee Osteoarthritis

Effects of Mulligan Mobilization With Movement as Compared to Kaltenborn Joint Mobilization in the Management of Knee Osteoarthritis

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06444945
Enrollment
40
Registered
2024-06-06
Start date
2024-06-10
Completion date
2024-12-30
Last updated
2024-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

This study is a randomised controlled trial and the purpose of this study is to determine the Effects of Mulligan mobilization with movement as compared to Kaltenborn joint mobilization in the management of knee osteoarthritis. To determine the effects of Mulligan MWM as compared to Kaltenborn joint mobilization in terms of pain, function, range of motion and gait in persons with knee osteoarthritis.

Interventions

Heating pad will be used for heating purpose.

TENS is used for symptomatic pain relief

It provides short term pain relief and to restore pain-free, functional movements by achieving full range at the joint

PROCEDUREKaltenborn joint mobilization

The purpose of joint mobilization is to restore normal, painless joint function. In restricted joints, this involves the restoration of joint play to normalize the roll-gliding that is essential to active movement.

Resistance training increases muscle strength by making your muscles work against a weight or force.

Sponsors

Foundation University Islamabad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Intervention model description

Parallel designed randomized control trial

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Individuals aged 40-70 years (Osama et al, 2022) * Having KOA history of no less than 3 months * Knee pain less than 8/10 on numeric pain rating scale (NPRS). * Radiological evidence of grade III or less on Kellgren classification * Patients referred from rehab department

Exclusion criteria

* Those with signs of serious pathology, such as malignancy, inflammatory disorder or infection. * History of trauma or fractures in lower extremity. * Signs of lumbar radiculopathy or myelopathy. * History of knee surgery or replacement. * Receiving intra-articular steroid therapy in the preceding two months.

Design outcomes

Primary

MeasureTime frameDescription
knee pain2 weeksknee pain will be measured using visual analogue scale (VAS) from 0-100mm.A higher score on VAS indicated greater pain.
Functional disability2 weeksknee functional disability will be assessed using Knee Osteoarthritis and Outcome Score(KOOS) with a score ranging from 0-100. A lower score on KOOS signifies greater functional disability
Knee range of motion2 weeksknee range of motion will be measured using a goniometer. A higher ROM signifies positive outcome.
Stride length2 weeksGait analysis will be done to analyze stride length. A greater stride length signifies positive outcome and prognosis.
Gait velocity2 weeksGait analysis will be done to analyze gait velocity. A greater gait velocity signifies positive outcome and prognosis.
Isometeric Muscle Strength2 weeksIsometeric Muscle Strength will be quantified using dynamometer. A higher score on dynamometer signifies greater muscle strength and good prognosis.
Walking related performance fatigability2 weekswalking related performance fatigability will be measured using 6 minute walk test. Greater fatigibility indicates poorer outcome.
Functional Capacity2 weeks5 repetition sit to stand test will be used to determine knee related functional capacity which will be quantified in terms of time. A smaller time will denote greater functional capacity.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026